Platelet-mediated thrombosis and drug-eluting stents

Circ Cardiovasc Interv. 2011 Dec 1;4(6):629-37. doi: 10.1161/CIRCINTERVENTIONS.111.964635.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clopidogrel
  • Coronary Thrombosis / epidemiology
  • Coronary Thrombosis / physiopathology*
  • Coronary Thrombosis / prevention & control*
  • Drug-Eluting Stents*
  • Equipment Design
  • Humans
  • Piperazines / pharmacology
  • Platelet Activation / drug effects
  • Platelet Activation / physiology*
  • Prasugrel Hydrochloride
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Risk Factors
  • Thiophenes / pharmacology
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / pharmacology

Substances

  • Piperazines
  • Purinergic P2Y Receptor Antagonists
  • Thiophenes
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticlopidine